Literature DB >> 26857438

B-cell acute lymphoblastic leukemia with mature phenotype and MLL rearrangement: report of five new cases and review of the literature.

Elisa Olga Sajaroff1, Adrian Mansini2, Patricia Rubio2, Cristina Noemí Alonso2, Marta S Gallego3, Mariela C Coccé3, Silvia Eandi-Eberle2, Andrea Raquel Bernasconi1, Maria Ampatzidou4, George Paterakis5, Stefanos I Papadhimitriou6, Loizos Petrikkos4, Vassilios Papadakis4, Sophia Polychronopoulou4, Jorge G Rossi1, Maria Sara Felice2.   

Abstract

The association between mature-B phenotype and MLL abnormalities in acute lymphoblastic leukemia (ALL) is a very unusual finding; only 14 pediatric cases have been reported so far. We describe the clinical and biological characteristics and outcome of five pediatric cases of newly diagnosed B lineage ALL with MLL abnormalities and mature immunophenotype based on light chain restriction and surface Ig expression. Blasts showed variable expression of CD10/CD34/TdT. MLL abnormalities with no MYC involvement were detected in all patients by G-banding, FISH, and/or RT-PCR. Three patients were treated according to Interfant protocol, one to ALLIC-09, and one received B-NHL-BFM-2004. All patients achieved complete remission and three of them relapsed. Despite the small cohort size, it could be postulated that B lineage ALL with MLL abnormalities and mature phenotype is a distinct entity that differs both from the typical Pro B ALL observed in infants and mature B-ALL with high MYC expression.

Entities:  

Keywords:  Acute lymphoblastic leukemia; MLL; mature phenotype

Mesh:

Substances:

Year:  2016        PMID: 26857438     DOI: 10.3109/10428194.2016.1141407

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  MLL rearranged acute lymphoblastic leukaemia presenting as a maxillary sinus mass with a discordant immunophenotypic profile from the bone marrow.

Authors:  Yunzu Michele Wang; Jun Qin Mo; Dennis John Kuo; Victor Wong
Journal:  BMJ Case Rep       Date:  2019-02-15

2.  Let's Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia.

Authors:  Dalma Deak; Cristina Pop; Alina-Andreea Zimta; Ancuta Jurj; Alexandra Ghiaur; Sergiu Pasca; Patric Teodorescu; Angela Dascalescu; Ion Antohe; Bogdan Ionescu; Catalin Constantinescu; Anca Onaciu; Raluca Munteanu; Ioana Berindan-Neagoe; Bobe Petrushev; Cristina Turcas; Sabina Iluta; Cristina Selicean; Mihnea Zdrenghea; Alina Tanase; Catalin Danaila; Anca Colita; Andrei Colita; Delia Dima; Daniel Coriu; Hermann Einsele; Ciprian Tomuleasa
Journal:  Front Immunol       Date:  2019-12-20       Impact factor: 7.561

Review 3.  Mature B cell acute lymphoblastic leukaemia with KMT2A-MLLT3 transcripts in children: three case reports and literature reviews.

Authors:  Yinghui Cui; Min Zhou; Pinli Zou; Xin Liao; Jianwen Xiao
Journal:  Orphanet J Rare Dis       Date:  2021-07-30       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.